Q2 2026 · Form 13F Ledger數據來源:SEC EDGAR  
H

HOLDER.TOP

誰持有什麼——美股機構持倉的季度賬本。
EN · 简 · 繁
機構 / Kynam Capital Management, LP
Form 13F · Q2 2026

Kynam Capital Management, LP

CIK 1907884申報日 2026-08-1413F-HR 在 EDGAR 查看原始申報 ↗
$18.1亿
申報組合市值
32
持倉數量
12
Quarters on record
Top 50
持倉數量

Kynam Capital Management, LP——持倉

共 32 個持倉中的前 32 名,按申報市值排名。股數變動與上一季度對比。
#證券股數股數環比市值佔其組合
1CLDX Celldex Therapeutics Inc New5.3M−8.9%$2.0亿10.9%
2SNDX Syndax Pharmaceuticals Inc8.1M+0.0%$1.8亿9.7%
3PCVX Vaxcyte Inc2.9M+0.0%$1.7亿9.4%
4COGT Cogent Biosciences Inc3.7M−9.2%$1.4亿7.8%
5VERA Vera Therapeutics Inc2.9M−15.0%$1.2亿6.9%
6VRDN Viridian Therapeutics Inc6.5M+175.6%$1.2亿6.6%
7TVTX Travere Therapeutics Inc2.0M+27.5%$1.1亿6.3%
8BEAM Beam Therapeutics Inc2.8M−22.9%$9750万5.4%
9URGN Urogen Pharma Ltd2.4M+8.3%$8958万5.0%
10LEGN Legend Biotech Corp3.0M+90.4%$8667万4.8%
11CTMX Cytomx Therapeutics Inc.21.7M+44.6%$8139万4.5%
12RLAY Relay Therapeutics Inc3.3M+131.7%$6174万3.4%
13CGEM Cullinan Therapeutics Inc3.1M+0.0%$5671万3.1%
14MBX Mbx Biosciences Inc934,799+0.0%$5160万2.9%
15IMCR Immunocore Hldgs Plc1.4M+55.4%$4366万2.4%
16NRIX Nurix Therapeutics Inc1.2M+0.0%$2898万1.6%
17STRO Sutro Biopharma Inc872,558+0.0%$2897万1.6%
18BCRX Biocryst Pharmaceuticals Inc2.5M−55.6%$2523万1.4%
19PHVS Pharvaris N V661,795+3.3%$2288万1.3%
20SMMT Summit Therapeutics Inc1.2M—$1748万1.0%
21PRLD Prelude Therapeutics Inc2.4M+51.6%$1287万0.7%
22INSM Insmed Inc100,000—$1066万0.6%
23BNR Burning Rock Biotech Ltd1.2M+0.9%$1052万0.6%
24GERN Geron Corp6.8M+0.0%$875万0.5%
25AMRN Amarin Corp Plc532,982+12.8%$850万0.5%
26ALEC Alector Inc3.8M+90.4%$766万0.4%
27PBLS Parabilis Medicines Inc250,000—$684万0.4%
28CRBU Caribou Biosciences Inc2.5M+0.0%$441万0.2%
29PRQR Proqr Thrapeutics N V1.6M+0.0%$291万0.2%
30CADL Candel Therapeutics Inc96,741−51.6%$100万0.1%
31ENGN Engene Therapeutics Inc457,855—$79万0.0%
32TRAW Traws Pharma Inc84,400—$7万0.0%
來源:經 SEC EDGAR 的 Form 13F 申報。持倉截至 2026 年 6 月 30 日。期權(看漲/看跌)不計入股數。